|

Doxycycline in Type II Diabetes

RECRUITINGPhase 1/2Sponsored by Mostafa Bahaa
Actively Recruiting
PhasePhase 1/2
SponsorMostafa Bahaa
Started2024-03-30
Est. completion2026-03-20
Eligibility
Age40 Years – 60 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06329882

Summary

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease characterized by hyperglycemia, weight loss, and cardio-metabolic complications. T2DM develops due to the progression of insulin resistance (IR), impairment of insulin insensitivity, and failure of the pancreatic β-cells to release sufficient amount of insulin in response to glucose burden

Eligibility

Age: 40 Years – 60 YearsHealthy volunteers accepted
Inclusion Criteria:

* Male or female sex more than 40 years old Newly diagnosed type II diabetes. HbA1c more than 6.5

Exclusion Criteria:

* Patient with chronic kidney disease, hepatic disorders, mental and psychiatric disorders, pregnancy, and lactation

Conditions3

DiabetesDiabetes Mellitus, Type 2Heart Disease

Interventions2

DoxycyclinSitagliptin 100mg

Related trials

Browse More Trials

Heart Disease trialsDiabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.